ResMed stock tumbled Friday after organic sales growth slowed somewhat in the second fiscal quarter. But one analyst remained upbeat on the "mega trends" driving the CPAP maker.Please watch the video ...

A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...

European Union regulators will review new information relating to the safety of Eisai Co.’s and Biogen Inc.’s medicine for ...

Danone's shares have fallen by 13% over five years, but the company has improved significantly, increasing revenues and free ...

Two of Europe’s biggest travel retailers, Heinemann and Avolta, are expanding in Iceland and Norway as air traffic rebounds ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

Several years ago, a little-known drug named Ozempic — previously used only to treat diabetes — emerged as a promising new ...

Wall Street is coming off a losing session after the Federal Reserve paused its interest rate-cutting campaign, leaving its ...

L OBITH, NEAR where the river Rhine enters the Netherlands, has been a border town ever since northern Europe has had borders. Buried nearby lie the remains of a Roman camp that in the first century ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a serious complication.

With new drug development, a significant increase in sales, and high potential with Mounjaro and Zepbound, here’s what we think of Eli Lilly’s stock ...

The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...